Document is current
Any future updates will be listed below
-
Authors
Beltran, S.
Nassif, M.
Vicencio, E.
Arcos, J.
Labrador, L.
Cortes, B. I.
Cortez, C.
Bergmann, C. A.
Espinoza, S.
Hernandez, M. F.
Matamala, J. M.
Bargsted, L.
Matus, S.
Rojas-Rivera, D.
Bertrand, M. J. M.
Medinas, D. B.
Hetz, C.
Manque, P. A.
Woehlbier, U. https://orcid.org/0000-0003-3114-9708
-
Funding
Funding for this research was provided by:
Fondo Nacional de Desarrollo Científico y Tecnológico (1150743, 3140110, 11160288, 11150579, 11180546, 1161284)
Muscular Dystrophy Association (575897, 382453)
Amyotrophic Lateral Sclerosis Association (468)
Comisión Nacional de Investigación Científica y Tecnológica (ACT1109)
Bruno and Ilse Frick Foundation for Research on ALS (20014-15)
ALS Therapy Alliance (2014-F-059)
- License Information
-
More Information
Article History
Received: 30 January 2019
Accepted: 11 March 2019
First Online: 27 March 2019
Ethics approval and consent to participate
: Post-mortem frozen spinal cord samples from sALS patients and control subjects were obtained from the Alzheimer Disease Research Center at Massachusetts General Hospital and Dr. Robert H. Brown laboratory at the Neurology Department of University of Massachusetts Medical School under approved Institutional Review Board protocol (FWA#00004009). We received de-identified samples in the role of collaborator; therefore, there was no need for patient consent form.
: All authors read and approved the final manuscript.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
